Abstract
Lymph node status is one of the most relevant factors for prognostic and therapeutic strategies for every cancer. It is a powerful predictor of survival in patients with early malignant tumors of the vulva, cervix, and uterus (1). For most cancers, the standard therapeutic approach consists of radical resection of the primary tumor with extensive lymphadenectomy. Malignant diseases require appropriate staging to ensure that the surgery does not exceed the minimum required (2). However, preoperative evaluation of lymph node status to establish the optimal extent of surgical dissection is difficult. It is well known that incorrect staging can affect short- and long-term morbidity and mortality.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Levenback C. Intraoperative lymphatic mapping and sentinel node identification: gynaecologic applications. Recent Results Cancer Res. 2000;157:150–158.
Zambo K, Koppan M, Paal A, Schmidt E, Tinneberg HR, Bodis J. Sentinel lymph nodes in gynaecological malignancies: frontline between TNM and clinical staging system? Eur J Nucl Med Mol Imaging. 2003;30:1684–1688.
Barranger E, Darai E. Lymphatic mapping for gynaecologic malignancies. Semin Oncol. 2004;31:392–402.
Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA. 1997;278:1096–1101.
Grahek D, Barranger E, Darai E, Uzan S, Talbot JN. Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynecological and breast cancers. Gynecol Obstet Fertil. 2005;33:371–381.
Paganelli G, De Cicco C, Chinol M. Sentinel node localization by lymphoscintigraphy: a reliable technique with widespread applications. Recent Results Cancer Res. 2000;157:121–129.
Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399.
Binder SW, Huang I, Fu YS, Hacker NF, Berek JS. Risk factors for the development of lymph node metastasis in vulvar squamous cell carcinoma. Gynecol Oncol. 1990;37:9–16.
Homesley HD, Bundy BN, Sedlis A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 1991;164:997–1003;discussion 1003–1004.
Levenback C, Burke TW, Gershenson DM, Morris M, Malpica A, Ross MI. Intraoperative lymphatic mapping for vulvar cancer. Obstet Gynecol. 1994;84:163–167.
Levenback C, Burke TW, Morris M, Malpica A, Lucas KR, Gershenson DM. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995;59:216–220.
Levenback C, Coleman RL, Burke TW, Bodurka-Bevers D, Wolf JK, Gershenson DM. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol. 2001;83:276–281.
Ansink AC, Sie-Go DM, van der Velden J, et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study. Cancer. 1999;86:652–656.
De Hullu JA, Doting E, Piers DA, et al. Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med. 1998;39:1381–1385.
Decesare SL, Fiorica JV, Roberts WS, et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol. 1997;66:425–428.
Sideri M, De Cicco C, Maggioni A, et al. Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia. Tumori. 2000;86:359–363.
De Cicco C, Sideri M, Bartolomei M, et al. Sentinel node biopsy in early vulvar cancer. Br J Cancer. 2000;82:295–299.
Molpus KL, Kelley MC, Johnson JE, Martin WH, Jones HW 3rd. Sentinel lymph node detection and microstaging in vulvar carcinoma. J Reprod Med. 2001;46:863–869.
Tavares MG, Sapienza MT, Galeb NA Jr, et al. The use of 99mTc-phytate for sentinel node mapping in melanoma, breast cancer and vulvar cancer: a study of 100 cases. Eur J Nucl Med. 2001;28:1597–1604.
Terada KY, Shimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol. 2000;76:40–44.
De Hullu JA, Hollema H, Piers DA, et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol. 2000;18:2811–2816.
Sliutz G, Reinthaller A, Lantzsch T, et al. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol. 2002;84:449–452.
Zambo K, Schmidt E, Hartmann T, et al. Preliminary experiences with sentinel lymph node detection in cases of vulvar malignancy. Eur J Nucl Med Mol Imaging. 2002;29:1198–1200.
Puig-Tintore LM, Ordi J, Vidal-Sicart S, et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol. 2003;88:29–34.
Moore RG, Granai CO, Gajewski W, Gordinier M, Steinhoff MM. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol. 2003;91:378–382.
Merisio C, Berretta R, Gualdi M, et al. Radioguided sentinel lymph node detection in vulvar cancer. Int J Gynecol Cancer. 2005;15:493–497.
Raspagliesi F, Ditto A, Fontanelli R, et al. False-negative sentinel node in patients with vulvar cancer: a case study. Int J Gynecol Cancer. 2003;13:361–363.
Plante M, Renaud MC, Roy M. Sentinel node evaluation in gynecologic cancer. Oncology (Williston Park, N. Y.). 2004;18:75–87.
Plentl AA, Friedman EA. Lymphatics of the cervix. In: Lymphatic System of the Female Genitalia. Philadelphia: WB Saunders; 1971:75.
Averette HE, Nguyen HN, Donato DM, et al. Radical hysterectomy for invasive cervical cancer. A 25-year prospective experience with the Miami technique. Cancer. 1993;71:1422–1437.
Inoue T, Chihara T, Morita K. The prognostic significance of the size of the largest nodes in metastatic carcinoma from the uterine cervix. Gynecol Oncol. 1984;19:187–193.
Landoni F, Maneo A, Colombo A, et al. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535–540.
Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and para-aortic lymph node metastasis in patients with Stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer. 1999;85:1547–1554.
Lecuru F, Taurelle R. Transperitoneal laparoscopic pelvic lymphadenectomy for gynecologic malignancies (I). Technique and results. Surg Endosc. 1998;12:1–6.
Echt ML, Finan MA, Hoffman MS, Kline RC, Roberts WS, Fiorica JV. Detection of sentinel lymph nodes with Lymphazurin in cervical, uterine, and vulvar malignancies. South Med J. 1999;92:204–208.
Medl M, Peters-Engl C, Schutz P, Vesely M, Sevelda P. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer. Anticancer Res. 2000;20:1133–1134.
O’Boyle JD, Coleman RL, Bernstein SG, Lifshitz S, Muller CY, Miller DS. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol. 2000;79:238–243.
Dargent D, Martin X, Mathevet P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol. 2000;79:411–415.
Kamprath S, Possover M, Schneider A. Laparoscopic sentinel lymph node detection in patients with cervical cancer. Am J Obstet Gynecol. 2000;182:1648.
Lantzsch T, Wolters M, Grimm J, et al. Sentinel node procedure in Ib cervical cancer: a preliminary series. Br J Cancer. 2001;14:791–794.
Verheijen RH, Pijpers R, van Diest PJ, Burger CW, Buist MR, Kenemans P. Sentinel node detection in cervical cancer. Obstet Gynecol. 2000;96:135–138.
Malur S, Krause N, Kohler C, Schneider A. Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol. 2001;80:254–257.
Levenback C, Coleman RL, Burke TW, et al. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002;20:688–693.
Barranger E, Grahek D, Cortez A, Talbot JN, Uzan S, Darai E. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer. 2003;97:3003–3009.
Chung YA, Kim SH, Sohn HS, Chung SK, Rhim CC, Namkoong SE. Usefulness of lymphoscintigraphy and intraoperative gamma probe detection in the identification of sentinel nodes in cervical cancer. Eur J Nucl Med Mol Imaging. 2003;30:1014–1017.
Martinez-Palones JM, Gil-Moreno A, Perez-Benavente MA, Roca I, Xercavins J. Intraoperative sentinel node identification in early stage cervical cancer using a combination of radiolabeled albumin injection and iso sulfan blue dye injection. Gynecol Oncol. 2004;92:845–850.
Pijpers R, Buist MR, van Lingen A, et al. The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy. Eur J Nucl Med Mol Imaging. 2004;31:1479–1486.
Niikura H, Okamura C, Akahira J, et al. Sentinel lymph node detection in early cervical cancer with combination 99mTc phytate and patent blue. Gynecol Oncol. 2004;94:528–532.
Angioli R, Palaia I, Cipriani C, et al. Role of sentinel lymph node biopsy procedure in cervical cancer: a critical point of view. Gynecol Oncol. 2005;96:504–509.
Hauspy J, Verkinderen L, De Pooter C, Dirix LY, van Dam PA. Sentinel node metastasis in the groin detected by technetium-labeled nanocolloid in a patient with cervical cancer. Gynecol Oncol. 2002;86:358–360.
Marchiole P, Buenerd A, Scoazec JY, Dargent D, Mathevet P. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer. 2004;100:2154–2159.
Larson DM, Johnson K, Olson KA. Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet Gynecol. 1992;79:998–1001.
DiSaia PJ, Creasman WT, Boronow RC, Blessing JA. Risk factors and recurrent patterns in Stage I endometrial cancer. Am J Obstet Gynecol. 1985;151:1009–1015.
Annual report on the results of treatment in gynecologic cancer. Int J Gynecol Obstet. 1989;28:189–190.
American Joint Committee on Cancer. In: Manual for Staging of Cancer. Philadelphia: Lippincott; 1992:155–157.
Belinson Jl, Lee KR, Badger GJ, Pretorius RG, Jarrell MA. Clinical stage I adenocarcinoma of the endometrium-analysis of recurrences and the potential benefit of staging lymphadenectomy. Gynecol Oncol. 1992;44:17–23.
Benedetti Panici Pl, Scambia G, Baiocchi G, Greggi S, Mancuso S. Technique and feasibility of radical paraaortic and pelvic lymphadenectomy for gynecologic malignancies: a prospective study. Int Gynecol Cancer. 1991;1:133–140.
Corn BW, Lanciano RM, Greven KM, et al. Impact of improved irradiation technique, age, and lymph node sampling on the severe complication rate of surgically staged endometrial cancer patients: a multivariate analysis. J Clin Oncol. 1994;12:510–515.
Arduino S, Leo L, Febo G, Tessarolo M, Wierdis T, Lanza A. Complications of pelvic and para-aortic lymphadenectomy in patients with endometrial cancer. Eur J Gynecol Oncol. 1997;18:208–210.
Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intra-abdominal lymphatic mapping to direct selective pelvic and para-aortic lymph adenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol. 1996;62:169–173.
Holub Z, Jabor A, Kliment L. Comparison of 2 procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynaecol Oncol. 2002;23:53–57.
Pelosi E, Arena V, Baudino B, et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl Med Commun. 2003;24:971–975.
Niikura H, Okamura C, Utsunomiya H, et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol. 2004;92:669–674.
Barranger E, Grahek D, Cortez A, Talbot JN, Uzan S, Darai E. Laparoscopic sentinel lymph node procedure using a combination of patent blue and radioisotope in women with cervical carcinoma. Cancer. 2003;97:3003–3009.
Raspagliesi F, Ditto A, Kusamura S, et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. Am J Obstet Gynecol. 2004;191:435–439.
Maccauro M, Lucignani G, Aliberti G. Sentinel lymph node detection following the hysteroscopic peritumoral injection of 99mTc-labelled albumin nanocolloids in endometrial cancer. Eur J Nucl Med Mol Imaging. 2005;32:569–74.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Bombardieri, E., Maccauro, M., Fontanelli, R., Raspagliesi, F., Paganelli, G. (2008). Sentinel Lymph Node Biopsy in Gynecologic Malignancies. In: Mariani, G., Giuliano, A.E., Strauss, H.W. (eds) Radioguided Surgery. Springer, New York, NY. https://doi.org/10.1007/978-0-387-38327-9_13
Download citation
DOI: https://doi.org/10.1007/978-0-387-38327-9_13
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-33684-8
Online ISBN: 978-0-387-38327-9
eBook Packages: MedicineMedicine (R0)